NCT01823900View on ClinicalTrials.gov

Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

March 31, 2012

Conditions

Healthy

Interventions

DRUG

Test formulation

Single administration of a combination tablet of Rosuvastatin 20mg and Olmesartan 40mg

DRUG

Reference formulation

Co-administration of Rosuvastatin 20mg tablet and Olmesartan 40mg tablet

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors

lead

Severance Hospital

OTHER

NCT01823900 - Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter